EMA invites comments on its future strategy

Sunday 31 January 2010

Location

United Kingdom

The European Medicines Agency (EMA) is inviting comments from industry, healthcare professionals and the public on its proposed strategy for the next five years, a period during which infectious disease and demographic change will put new demands on the drug regulatory system.

Full text available to subscribers only. Click here for information on subscribing to MedNous.